Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tiago Torres

Showing results (161-170 of 274) with videos related to

Pageof 28
Sort By:
European Journal of Dermatology : EJD|July 9, 2010
Paecilomyces lilacinus in transplant patients: an emerging infectionAristóteles Rosmaninho, Tiago Torres, Glória Velho, et al.
Skin Therapy Letter|December 10, 2025
OX40 Ligand Inhibitors for Moderate-to-Severe Atopic Dermatitis: A Review of Phase II Clinical Trial DataSiddhartha Sood, Alim R Devani, Tiago Torres, et al.
The Journal of Dermatology|October 17, 2013
Framingham Risk Score underestimates cardiovascular disease risk in severe psoriatic patients: implications in cardiovascular risk factors management and primary prevention of cardiovascular diseaseTiago Torres, Rita Sales, Carlos Vasconcelos, et al.
Acta Medica Portuguesa|February 16, 2024
[Letter to the Editor - "Guidelines for Management of Patients with Hidradenitis Suppurativa": The Importance of Collaboration with Infectious Diseases]João Matos, Isabel Furtado, Tiago Torres, et al.
Journal of the American Academy of Dermatology|April 18, 2012
The role of antinuclear autoantibodies in patients with psoriasis treated with anti-tumor necrosis factor-alpha agents: a retrospective long-term studyRosita Saraceno, Francesca Specchio, Tiago Torres, et al.
Acta Medica Portuguesa|August 4, 2012
[Psoriasis induced by infliximab]Iolanda C Fernandes, Tiago Torres, Madalena Sanches, et al.
Drugs in Context|March 21, 2024
Tildrakizumab for the treatment of moderate-to-severe psoriasis: a 52-week, real-world Portuguese multicentric studyTiago Torres, Paulo Varela, Pedro Mendes Bastos, et al.
American Journal of Clinical Dermatology|December 22, 2025
Past, Present, and Future of Sodium Hypochlorite in Dermatology: A Scoping ReviewChristy H Chang, Maura Devine, Deborah Woo, et al.
International Journal of Dermatology|August 2, 2024
Pregnancy and breastfeeding outcome in patients with atopic dermatitis treated with dupilumab: the clinical experience of three centersJoana Xará, Pedro Farinha, Ana M Lé, et al.
Archives of Dermatological Research|May 23, 2014
Complement C3 as a marker of cardiometabolic risk in psoriasisTiago Torres, Nuno Bettencourt, Denisa Mendonça, et al.
Pageof 28

Showing results (161-170 of 274) with videos related to

Sort By:
Pageof 28
European Journal of Dermatology : EJD|July 9, 2010
Paecilomyces lilacinus in transplant patients: an emerging infectionAristóteles Rosmaninho, Tiago Torres, Glória Velho, et al.
Skin Therapy Letter|December 10, 2025
OX40 Ligand Inhibitors for Moderate-to-Severe Atopic Dermatitis: A Review of Phase II Clinical Trial DataSiddhartha Sood, Alim R Devani, Tiago Torres, et al.
The Journal of Dermatology|October 17, 2013
Framingham Risk Score underestimates cardiovascular disease risk in severe psoriatic patients: implications in cardiovascular risk factors management and primary prevention of cardiovascular diseaseTiago Torres, Rita Sales, Carlos Vasconcelos, et al.
Acta Medica Portuguesa|February 16, 2024
[Letter to the Editor - "Guidelines for Management of Patients with Hidradenitis Suppurativa": The Importance of Collaboration with Infectious Diseases]João Matos, Isabel Furtado, Tiago Torres, et al.
Journal of the American Academy of Dermatology|April 18, 2012
The role of antinuclear autoantibodies in patients with psoriasis treated with anti-tumor necrosis factor-alpha agents: a retrospective long-term studyRosita Saraceno, Francesca Specchio, Tiago Torres, et al.
Acta Medica Portuguesa|August 4, 2012
[Psoriasis induced by infliximab]Iolanda C Fernandes, Tiago Torres, Madalena Sanches, et al.
Drugs in Context|March 21, 2024
Tildrakizumab for the treatment of moderate-to-severe psoriasis: a 52-week, real-world Portuguese multicentric studyTiago Torres, Paulo Varela, Pedro Mendes Bastos, et al.
American Journal of Clinical Dermatology|December 22, 2025
Past, Present, and Future of Sodium Hypochlorite in Dermatology: A Scoping ReviewChristy H Chang, Maura Devine, Deborah Woo, et al.
International Journal of Dermatology|August 2, 2024
Pregnancy and breastfeeding outcome in patients with atopic dermatitis treated with dupilumab: the clinical experience of three centersJoana Xará, Pedro Farinha, Ana M Lé, et al.
Archives of Dermatological Research|May 23, 2014
Complement C3 as a marker of cardiometabolic risk in psoriasisTiago Torres, Nuno Bettencourt, Denisa Mendonça, et al.
Pageof 28